Condition

Idiopathic Pulmonary Fibrosis

ClinicalTrials.gov condition label

Clinical trials31
Recruiting4
Common interventions25
Lead sponsors shown15

Clinical trials

31 shown
Validation of the C-mo System - Cough MonitoringNCT05989698 · 2023-12-11
RECRUITING
Effects of Pulmonary Diseases and Their Treatment on Cardiac FunctionNCT05042219 · 2022-06-01
RECRUITING
Lung and Bone Marrow Transplantation for Lung and Bone Marrow FailureNCT03500731 · 2018-04-19
RECRUITING
Controls for Respiratory DiseasesNCT03120481 · 2017-04-10
RECRUITING
New Diagnostic Approaches in the Management of Inflammatory Lung DiseasesNCT07723638 · 2026-09-01
NOT_YET_RECRUITING
Study of Single and Multiple Oral Doses of SCB0020160 in Healthy Adult Male SubjectsNCT07682337 · 2026-06-29
NOT_YET_RECRUITING
PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPFNCT06683612 · 2024-12-09
COMPLETED
Respiratory Rate Validation Study - HiCardi+ Wearable Patch Device, Mezoo Co., Ltd.NCT05863091 · 2023-03-09
UNKNOWN
First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy SubjectsNCT05427253 · 2022-06-08
COMPLETED
Medication Adherence and Non-adherence in Adults With Rare DiseaseNCT04541875 · 2021-01-01
WITHDRAWN
Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary DiseasesNCT06909968 · 2020-12-14
COMPLETED
Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory DiseasesNCT04693975 · 2020-10-16
UNKNOWN
Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 InfectionNCT04326036 · 2020-03-25
UNKNOWN
A Study of Patients With Chronic DiseaseNCT04263727 · 2020-02-27
TERMINATED
Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPDNCT04257630 · 2020-02-06
COMPLETED
Impact of Air Pollution on Chronic Respiratory DiseasesNCT03813810 · 2019-01-25
UNKNOWN
Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary HypertensionNCT02951429 · 2016-12-31
COMPLETED
3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPFNCT02267655 · 2015-05-01
COMPLETED
Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male SubjectsNCT02397005 · 2015-03-01
UNKNOWN
Auto-titrating Oxygen in Chronic Respiratory FailureNCT02248064 · 2014-07-01
COMPLETED
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIATNCT02036970 · 2014-05-31
COMPLETED
Study of Default Options in Advance DirectivesNCT01817686 · 2013-03-01
COMPLETED
Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy PatientsNCT01382368 · 2011-09-01
UNKNOWN
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.NCT01265888 · 2011-03-01
COMPLETED
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary FibrosisNCT00879229 · 2009-07-01
TERMINATED
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial HypertensionNCT00705133 · 2008-07-01
COMPLETED
Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary FibrosisNCT00703339 · 2008-06-01
TERMINATED
Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment StudyNCT00637065 · 2008-04-01
UNKNOWN
Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With BosentanNCT00625469 · 2007-10-01
WITHDRAWN
Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With SildenafilNCT00625079 · 2007-02-01
WITHDRAWN
The Occurence of Inflammation and Oxidative Stress in Lung DiseasesNCT00512967 · 2005-09-01
COMPLETED

Common interventions

PlaceboDRUG6SildenafilDRUG3BosentanDRUG2AlemtuzumabDRUG1AmbrisentanDRUG1Auto-titrating oxygen systemDEVICE1Bardoxolone methylDRUG1C-mo SystemDEVICE1C106 solutionDRUG1Cardiac MRIDIAGNOSTIC_TEST1CD3/CD19 negative hematopoietic stem cellsBIOLOGICAL1Centricyte 1000DEVICE1Comfort Default AD formsOTHER1FludarabineDRUG1G-CSFDRUG1HiCardi+DEVICE1HydroxyureaDRUG1Inhaled Nitric OxideDRUG1inhaled Nitric Oxide - 30 mcg/kg IBW/hrDRUG1inhaled Nitric Oxide 5,10,15 mcg/Kg IBW/hrDRUG1inhaled nitric oxide 75 mcg/kg IBW/hrDRUG1Integrated Precision Medicine PlatformOTHER1IV Deployment Of cSVF In Sterile Normal Saline IV SolutionPROCEDURE1Liberase Enzyme (Roche)DRUG1Life Extension Default AD formsOTHER1

Trial status mix

COMPLETED12
UNKNOWN7
RECRUITING4
TERMINATED3
WITHDRAWN3
NOT_YET_RECRUITING2

Phase mix

PHASE16
PHASE26
NA5
PHASE44
EARLY_PHASE11
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.